Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Lanteri, Marion C ^a   Diamond, Michael S ^b   Law, Jacqueline P ^a   Chew, Glen M ^c   Wu, Shiquan ^a   Inglis, Heather C ^a   Wong, Derek ^a   Busch, Michael P ^a,d   Norris, Philip J ^a,d   Ndhlovu, Lishomwa C ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; PROGRAMMED DEATH 1 RECEPTOR; CD57 ANTIGEN; HAVCR2 PROTEIN, HUMAN; MEMBRANE PROTEIN; PDCD1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASYMPTOMATIC INFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOKINE RELEASE; DISEASE ASSOCIATION; FEMALE; FLAVIVIRUS INFECTION; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MALE; MIDDLE AGED; PROTEIN EXPRESSION; T LYMPHOCYTE; VERY ELDERLY; WEST NILE VIRUS INFECTION; YOUNG ADULT; ADOLESCENT; ASYMPTOMATIC DISEASE; GENE EXPRESSION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PATHOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VIROLOGY; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD28; ANTIGENS, CD57; ASYMPTOMATIC DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; SEVERITY OF ILLNESS INDEX; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84898636382     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092134     Document Type: Article

References (32)

1. CDC (2012) Available at http://www.cdc.gov/ncidod/dvbid/westnile/.
2. Petersen LR, Carson PJ, Biggerstaff BJ, Custer B, Borchardt SM, et al. (2012) Estimated cumulative incidence of West Nile virus infection in US adults, 199922010. Epidemiol Infect: 125.
3. Carson PJ, Borchardt SM, Custer B, Prince HE, Dunn-Williams J, et al. (2012) Neuroinvasive disease and west nile virus infection, north dakota, USA, 199922008. Emerg Infect Dis 18: 6842686.
4. Bigham AW, Buckingham KJ, Husain S, Emond MJ, Bofferding KM, et al. (2011) Host genetic risk factors for West Nile virus infection and disease progression. PLoS ONE 6: e24745.
5. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, et al. (2006) CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 203: 35240.
6. Lanteri MC, Kaidarova Z, Peterson T, Cate S, Custer B, et al. (2011) Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study. PLoS ONE 6: e22948.
7. Suthar MS, Diamond MS, Gale M Jr (2013) West Nile virus infection and immunity. Nat Rev Microbiol 11: 1152128.
8. Kumar D, Drebot MA, Wong SJ, Lim G, Artsob H, et al. (2004) A seroprevalence study of west nile virus infection in solid organ transplant recipients. Am J Transplant 4: 188321888.
9. Wang Y, Lobigs M, Lee E, Mullbacher A (2003) CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77: 13323213334.
10. Wang Y, Lobigs M, Lee E, Mullbacher A (2004) Exocytosis and Fas mediated cytolytic mechanisms exert protection from West Nile virus induced encephalitis in mice. Immunol Cell Biol 82: 1702173.
11. Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT (2004) CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 172: 412324132.
12. Wherry EJ (2011) T cell exhaustion. Nat Immunol 12: 4922499.
13. Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, et al. (2007) Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 6702684.
14. Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, et al. (2009) Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 119: 326623277.
15. Pfeiffer IA, Zinser E, Strasser E, Stein MF, Dorrie J, et al. (2013) Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes. Immunobiology 218: 139221401.
16. Kim S, Li L, McMurtrey CP, Hildebrand WH, Weidanz JA, et al. (2010) Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection. J Immunol 184: 442324430.
17. Lanteri MC, Heitman JW, Owen RE, Busch T, Gefter N, et al. (2008) Comprehensive analysis of west nile virus-specific T cell responses in humans. J Infect Dis 197: 129621306.
18. Tobler LH, Cameron MJ, Lanteri MC, Prince HE, Danesh A, et al. (2008) Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors. J Infect Dis 198: 9792983.
19. McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, et al. (2010) Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 120: 454624557.
20. Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, et al. (2009) Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 5: e1000313.
21. Nakamoto N, Kaplan DE, Coleclough J, Li Y, Valiga ME, et al. (2008) Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 134: 192721937, 1937 e192121922.
22. Ngiow SF, von Scheidt B, Akiba H, Yagita H, Teng MW, et al. (2011) Anti-TIM3 antibody promotes T cell IFN-gamma-mediated antitumor immunity and suppresses established tumors. Cancer Res 71: 354023551.
23. Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, et al. (2010) Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 207: 218722194.
24. Qiu Y, Chen J, Liao H, Zhang Y, Wang H, et al. (2012) Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions. PLoS Pathog 8: e1002984.
25. Lai L, Lee TH, Tobler L, Wen L, Shi P, et al. (2011) Relative distribution of West Nile virus RNA in blood compartments: implications for blood donor nucleic acid amplification technology screening. Transfusion.
26. Nett RJ, Kuehnert MJ, Ison MG, Orlowski JP, Fischer M, et al. (2012) Current practices and evaluation of screening solid organ donors for West Nile virus. Transpl Infect Dis 14: 2682277.
27. Appler KK, Brown AN, Stewart BS, Behr MJ, Demarest VL, et al. (2010) Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS ONE 5: e10649.
28. Cho JL, Roche MI, Sandall B, Brass AL, Seed B, et al. (2012) Enhanced Tim3 activity improves survival after influenza infection. J Immunol 189: 287922889.
29. Braciale TJ, Sun J, Kim TS (2012) Regulating the adaptive immune response to respiratory virus infection. Nat Rev Immunol 12: 2952305.
30. Mujib S, Jones RB, Lo C, Aidarus N, Clayton K, et al. (2012) Antigen-Independent Induction of Tim-3 Expression on Human T Cells by the Common gamma-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Is Associated with Proliferation and Is Dependent on the Phosphoinositide 3-Kinase Pathway. J Immunol.
31. Ndhlovu LC, Lopez-Verges S, Barbour JD, Jones RB, Jha AR, et al. (2012) Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 119: 373423743.
32. Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, et al. (2009) Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 83: 912229130.